Search results for “Multi gene” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 487 patents, we discovered top 227 key players by total patent application. DowElanco Ltd., Modalis Therapeutics Corp., Biocytogen Pharmaceuticals (Beijing) Co., Ltd. are dominant in this area. They take 14.58% of the total patent filing.
United States
Patent: 44
STARTUP
Tokyo-to, Japan
Patent: 14
Beijing Shi, China
Patent: 13
California, United States
Patent: 11
Massachusetts, United States
Patent: 10
New York, United States
Patent: 9
New South Wales, Australia
Patent: 9
Colorado, United States
Patent: 9
Beijing Shi, China
Patent: 9
Hong Kong SAR, China
Patent: 9
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 32 patents, we discovered top 15 start-ups by total patent application. Modalis Therapeutics Corp., AnchorDX Corp., Guangzhou Kangliming Biosciences Technology Co. Ltd. are active in this area.
STARTUP
Tokyo-to, Japan
Patent: 14
STARTUP
Guangdong Sheng, China
Patent: 3
STARTUP
Guangdong Sheng, China
Patent: 2
STARTUP
MIODx Inc.
California, United States
Patent: 2
STARTUP
Jiangsu Sheng, China
Patent: 1
STARTUP
New York, United States
Patent: 1
STARTUP
Alberta, Canada
Patent: 1
STARTUP
Shanghai Shi, China
Patent: 1
STARTUP
MyOme, Inc.
California, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 402 patents applied in the last 5 years. We discover 243 most active companies in this area. The fast-growing Modalis Therapeutics Corp., Biocytogen Pharmaceuticals (Beijing) Co., Ltd., OncoSec Medical, Inc. take 9.45% of patent filing during this period.
STARTUP
Tokyo-to, Japan
Patent: 14
Beijing Shi, China
Patent: 13
California, United States
Patent: 11
Beijing Shi, China
Patent: 9
Beijing Xianyun Qiyuan Technology Co., Ltd.
Beijing Shi, China
Patent: 9
Hong Kong SAR, China
Patent: 9
Shanghai Shi, China
Patent: 8
Jiangsu Sheng, China
Patent: 7
Guangdong Sheng, China
Patent: 7
Hubei Sheng, China
Patent: 7
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 402 patents in last 5 years, we discover 207 new entrants. Modalis Therapeutics Corp., Biocytogen Pharmaceuticals (Beijing) Co., Ltd., OncoSec Medical, Inc. are the most active new entrants in this area.
STARTUP
Tokyo-to, Japan
Patent: 14
Beijing Shi, China
Patent: 13
California, United States
Patent: 11
Beijing Shi, China
Patent: 9
Beijing Xianyun Qiyuan Technology Co., Ltd.
Beijing Shi, China
Patent: 9
Hong Kong SAR, China
Patent: 9
Shanghai Shi, China
Patent: 8
Jiangsu Sheng, China
Patent: 7
Hubei Sheng, China
Patent: 7
Guangdong Sheng, China
Patent: 7
Research Institutions
Order by:
Innovation Intensity
With the analysis among 288 patents, we discovered top 89 universities and scientific research institutions by total patent application. South China Agricultural University, Jiangnan University, Huazhong Agricultural University are dominant in this area. They take 10.42% of the total patent filing.
Guangdong Sheng, China
Patent: 15
Jiangsu Sheng, China
Patent: 7
Hubei Sheng, China
Patent: 7
Shandong Sheng, China
Patent: 5
Zhejiang Sheng, China
Patent: 4
China Medical University (Taiwan)
Taiwan Province, China
Patent: 4
Chongqing Shi, China
Patent: 4
Jilin Sheng, China
Patent: 3
ZURICH, Switzerland
Patent: 3
Massachusetts, United States
Patent: 3
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: